GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since their inception in 2017, their goal has been to develop each of the 260+ clinical IHC antibodies in-house, making them the first and only institution to date to achieve this. GenomeMe Lab is on track to reach this R&D goal by the end of 2021 - hitting a monumental milestone in the history of their company’s development.
Because GenomeMe develops and manufactures all of their antibodies in-house, they are able to offer their end user customers the best value and quality. GenomeMe Lab Inc. is rising to be a dominant player in diagnostic IHC applications, an increasingly essential part of future precision medicine technologies.
GenomeMe Lab Inc. has the following certifications:
- ISO 13485:2016: Products manufactured under Quality Management System conforming with ISO 13485:2016 as certified by Intertek.
- CE IVD: Our products are CE IVD Certified for diagnostic use.
- NordiQC: External quality assessments by NordiQC, an international profiency testing program for diagnostic IHC.
The prices are on request! Contact Us by e-mail email@example.com